1. Home
  2. NEO vs PRCT Comparison

NEO vs PRCT Comparison

Compare NEO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$13.05

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$31.12

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
PRCT
Founded
2001
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
NEO
PRCT
Price
$13.05
$31.12
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$11.38
$51.13
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
02-17-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$709,162,000.00
$299,907,000.00
Revenue This Year
$10.87
$48.30
Revenue Next Year
$9.84
$29.44
P/E Ratio
N/A
N/A
Revenue Growth
10.10
50.07
52 Week Low
$4.72
$27.80
52 Week High
$16.18
$85.00

Technical Indicators

Market Signals
Indicator
NEO
PRCT
Relative Strength Index (RSI) 62.37 43.13
Support Level $11.93 $30.60
Resistance Level $13.74 $35.20
Average True Range (ATR) 0.59 1.48
MACD 0.03 -0.24
Stochastic Oscillator 69.46 24.57

Price Performance

Historical Comparison
NEO
PRCT

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: